China NMPA GMP Inspection Guidance: Preparing for the November 1, 2026 Deadline

Medical Device Global Market Access · Sep 20, 2026 · 5m

China's NMPA has released new mandatory GMP Inspection Guidance Principles, effective November 1, 2026. This episode breaks down the critical changes, including the new deficiency classification system (critical, major, and minor) and the impact on both production-license and post-market inspections. We provide practical, actionable steps for medical device manufacturers to conduct gap analyses, update internal audit programs, and prepare their quality systems for this more stringent regulatory environment to avoid enforcement actions and market access delays. Key Questions: - What are the…